Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Knowles

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Genomics|April 18, 1998
Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33T Habuchi, M Luscombe, P A Elder, et al.
The Journal of Pathology|August 2, 2007
FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancerD C Tomlinson, O Baldo, P Harnden, et al.
Oncogene|October 19, 1995
Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor lociT Habuchi, J Devlin, P A Elder, et al.
British Journal of Cancer|June 9, 1999
Somatic mutation of PTEN in bladder carcinomaJ S Aveyard, A Skilleter, T Habuchi, et al.
International Journal of Cancer|February 27, 1999
Partial allelotype of schistosomiasis-associated bladder cancerM E Shaw, P A Elder, A Abbas, et al.
Carcinogenesis|July 1, 1985
N-methyl-N-nitrosourea induces dysplasia and cell surface markers of neoplasia in long-term rat bladder organ culturesM A Knowles, H Jani, R M Hicks, et al.
Genes, Chromosomes & Cancer|September 1, 1999
Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancerH Nishiyama, T Takahashi, Y Kakehi, et al.
Methods in Cell Biology|January 1, 1980
Organ culture of normal human bladder: choice of starting material and culture characteristicsM A Knowles, R M Hicks, R J Berry, et al.
Nucleic Acids Research|May 6, 2005
Inhibition of double-strand break non-homologous end-joining by cisplatin adducts in human cell extractsC P Diggle, J Bentley, M A Knowles, et al.
Genes, Chromosomes & Cancer|October 1, 1996
Fluorescence in situ hybridization deletion mapping at 4p16.3 in bladder cancer cell lines refines the localisation of the critical interval to 30 kbS M Bell, J Zuo, R M Myers, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Genomics|April 18, 1998
Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33T Habuchi, M Luscombe, P A Elder, et al.
The Journal of Pathology|August 2, 2007
FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancerD C Tomlinson, O Baldo, P Harnden, et al.
Oncogene|October 19, 1995
Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor lociT Habuchi, J Devlin, P A Elder, et al.
British Journal of Cancer|June 9, 1999
Somatic mutation of PTEN in bladder carcinomaJ S Aveyard, A Skilleter, T Habuchi, et al.
International Journal of Cancer|February 27, 1999
Partial allelotype of schistosomiasis-associated bladder cancerM E Shaw, P A Elder, A Abbas, et al.
Carcinogenesis|July 1, 1985
N-methyl-N-nitrosourea induces dysplasia and cell surface markers of neoplasia in long-term rat bladder organ culturesM A Knowles, H Jani, R M Hicks, et al.
Genes, Chromosomes & Cancer|September 1, 1999
Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancerH Nishiyama, T Takahashi, Y Kakehi, et al.
Methods in Cell Biology|January 1, 1980
Organ culture of normal human bladder: choice of starting material and culture characteristicsM A Knowles, R M Hicks, R J Berry, et al.
Nucleic Acids Research|May 6, 2005
Inhibition of double-strand break non-homologous end-joining by cisplatin adducts in human cell extractsC P Diggle, J Bentley, M A Knowles, et al.
Genes, Chromosomes & Cancer|October 1, 1996
Fluorescence in situ hybridization deletion mapping at 4p16.3 in bladder cancer cell lines refines the localisation of the critical interval to 30 kbS M Bell, J Zuo, R M Myers, et al.
Pageof 10